Vazra-SP Tablets

Product Description

Vazra-SP combines aceclofenac and paracetamol with serratiopeptidase. It is intended for physician-directed treatment of selected painful inflammatory conditions where swelling or edema is also present.

The combination should not be used without medical advice. NSAID-related gastrointestinal, renal and cardiovascular precautions and total daily paracetamol exposure must be considered by the prescriber.

Composition / Nutritional Information

• Aceclofenac IP — 100 mg
• Paracetamol IP — 325 mg
• Serratiopeptidase IP — 15 mg
• Excipients — q.s.

Indications / Intended Support

• Musculoskeletal injuries and pain
• Low back or joint pain
• Dental inflammatory pain
• Post-operative pain and swelling
• Other inflammatory conditions when prescribed

Key Product Features

• Analgesic and anti-inflammatory combination
• Serratiopeptidase component for swelling-focused therapy
• Fixed-dose tablet
• Physician-supervised pain management